Our eShop will be on maintenance from April 29th, 10:00 PM until May 5th 2025, 12:01 AM CEST. During this period only quoting is possible. Purchasing is not possible. Please cover your demands for this period before April 29th.

Virus Clearance Services

Confidence® Validation Services provide GLP and non-GLP virus clearance studies for any purification technology, as well as expert consultation.
Item No.: 
Virus-Clearance-Services
Availability: 
*Custom/bulk order quotes are provided within 72 hours of request.
Virus clearance studies are an essential step to get a biologic into clinical trials and ultimately to market. The goal of these studies is to evaluate the ability of a downstream unit operational step to inactivate or remove viral contamination and provide assurance of the virus safety of the drug product. Sartorius offers GLP as well as non-GLP virus clearance studies and provide consultancy on study design and regulatory requirement.

Benefits

  • Fast Turnaround:  Thanks to optimized project management, GLP Phase 1 studies are completed rapidly, with 9-week turnaround times
  • Highly Purified Viruses:  We use single level highly purified viruses for all removal and inactivation steps to achieve the highest possible log reduction values.
  • Proven Experience:  Our Confidence® team brings more than 60 years of experience and 700 completed projects1 to every virus clearance study.
  • Customer-Focused Services:  Single Point of Contact & perform Virus Clearance Studies remotely at no extra cost, eliminating the need for a sponsor to travel to our test facilities.
  • Technical & Regulatory Support: Access to Sartorius technical experts across Process Consultancy, Regulatory Affairs and Technical Specialists
  • Holistic Solutions:  With Sartorius, biopharma customers receive a comprehensive solution, including Downstream Consumables and Virus Clearance Validation Services, all under one roof.

1 - experience gained in Sartorius and at external CRO’s.

Applications

  • Purification process
  • Manufacturing processes using animal- or human-derived products

Services

  • GLP phase I studies
  • GLP phase III studies
  • Non-GLP feasibility studies
  • Viruses available:   MuLV, MVM, PPV, PRV, Reo3, SV40, BVDV, EMCV, HAV, HSV-1, PI3
  • Purification methods:  Solvent | Detergent, Heat Treatment and low pH inactivation, Chromatography (e.g., Affinity, AEX, CEX, HIC, MX, SEC), Virus filtration, and other virus clearance process steps (e.g., pasteurisation) on request

Questions & Answers (5)

Virus clearance is a where we assess a (Biologics) manufacturing process step to inactivate or remove viruses and transmissible spongiform encephalopathy (TSE) agents.

´